| Autor: |
Yuzbashev T; Rothamsted Research., Yuzbasheva E; BioMediCan Inc., Melkina O; GosNIIgenetika., Patel D; Imperial College London., Bubnov D; GosNIIgenetika., Dietz H; Kaesler Nutrition GmbH., Ledesma-Amaro R; Imperial College London. |
| Jazyk: |
angličtina |
| Zdroj: |
Research square [Res Sq] 2023 Apr 04. Date of Electronic Publication: 2023 Apr 04. |
| DOI: |
10.21203/rs.3.rs-2738543/v1 |
| Abstrakt: |
CRISPR/Cas9-based technologies are revolutionising the way we engineer microbial cells. One of the key advantages of CRISPR in strain design is that it enables chromosomal integration of marker-free DNA, eliminating laborious and often inefficient marker recovery procedures. Despite the benefits, assembling CRISPR/Cas9 editing systems is still not a straightforward process, which may prevent its use and applications. In this work, we have identified some of the main limitations of current Cas9 toolkits and designed improvements with the goal of making CRISPR technologies easier to access and implement. These include 1) A system to quickly switch between marker-free and marker-based integration constructs using both a Cre-expressing and standard Escherichia coli strains, 2) the ability to redirect multigene integration cassettes into alternative genomic loci via Golden Gate-based exchange of homology arms, 3) a rapid, simple in-vivo method to assembly guide RNA sequences via recombineering between Cas9-helper plasmids and single oligonucleotides. We combine these methodologies with well-established technologies into a comprehensive toolkit for efficient metabolic engineering using CRISPR/Cas9. As a proof of concept, we generated and characterized a library of 137 promoters and built a de novo Yarrowia lipolytica strain synthetizing 373.8 mg/L homogentisic acid. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
